How CAH Causes Both Precocious Puberty and Hypogonadotropic Hypogonadism
CAH causes precocious puberty in childhood through peripheral androgen excess that advances bone age and can trigger early activation of the hypothalamic-pituitary-gonadal (HPG) axis, while in adulthood, chronic androgen exposure suppresses gonadotropins leading to hypogonadotropic hypogonadism—two distinct mechanisms operating at different life stages.
Mechanism of Precocious Puberty in Childhood
Peripheral Precocious Puberty (Primary Mechanism)
Excess adrenal androgens from impaired cortisol synthesis are diverted to sex hormone biosynthesis, causing rapid postnatal growth and sexual precocity in untreated or poorly controlled CAH 1.
The cortisol synthetic block leads to ACTH-driven adrenal stimulation, with accumulation of cortisol precursors that are shunted toward androgen production 1.
This results in accelerated linear growth and advanced bone age during early childhood, particularly in the first 2 years of life in children who later develop central precocious puberty 2.
Central Precocious Puberty (Secondary Complication)
Chronic androgen exposure can trigger premature activation of the HPG axis, converting peripheral precocious puberty into true central precocious puberty (CPP) 3, 2.
CPP in CAH typically occurs in children with late initiation of treatment or poor compliance with glucocorticoid therapy 2.
Children who develop CPP show significantly accelerated linear growth and advanced bone age during infancy compared to CAH patients who do not develop CPP 2.
The mean age of onset differs: central precocious puberty presents earlier (mean 3 years, range 2-6) compared to peripheral precocious puberty (mean 5.25 years, range 3.62-7.0) 4.
Mechanism of Hypogonadotropic Hypogonadism in Adulthood
Chronic Androgen Suppression of the HPG Axis
Prolonged exposure to elevated adrenal androgens (including androstenedione and 11-oxygenated C-19 androgens) suppresses gonadotropin secretion through negative feedback on the hypothalamus and pituitary 5.
In males, secondary gonadal failure occurs due to poor hormonal control, with chronic androgen excess inhibiting LH and FSH secretion 5.
In females, overproduction of adrenal androgens and progestins disrupts normal HPG axis function, leading to menstrual disturbances and anovulation 6, 5.
Additional Gonadal Damage
In males, testicular adrenal rest tumors (TART) cause primary gonadal failure by compressing and damaging normal testicular tissue 6, 5.
TART originates from aberrant adrenal tissue in the testes and is thought to develop from chronic ACTH stimulation in poorly controlled CAH 6.
Low morning testosterone in males with large TART indicates impaired Leydig cell function, representing combined primary and secondary hypogonadism 7.
Clinical Implications and Monitoring
Prevention Strategy
Proper glucocorticoid replacement to achieve adequate control of hyperandrogenemia during early life may prevent development of central precocious puberty 2.
Glucocorticoid dosage should be minimized to avoid iatrogenic Cushing's syndrome while maintaining adequate androgen suppression 1.
Childhood Management
GnRH agonist therapy should be considered for children with CAH complicated by CPP to augment linear growth and diminish bone age advancement, particularly in those without extremely advanced bone age 3.
GnRHa treatment (3.75 mg every 4 weeks, increased to 7.5 mg if needed) effectively arrests puberty manifestations, decelerates growth velocity, and improves predicted adult height 3.
Adult Monitoring
Regular evaluation for TART using ultrasonography is recommended from the start of puberty or earlier when poor hormonal control is present 5.
In males, testosterone levels alone should not be used to assess disease control because they primarily reflect gonadal rather than adrenal activity; the androstenedione-to-testosterone ratio is required 7.
In females, regularity of the menstrual cycle should be evaluated as a marker of adequate hormonal control and HPG axis function 5.
Optimal hormonal control is the key for adequate gonadal function in all patients with CAH, requiring regular measurements of adrenal steroids and markers of the HPG axis 5.
Common Pitfalls
Normalizing 17-OHP levels completely may lead to overtreatment with supraphysiological glucocorticoid doses, worsening metabolic outcomes 7.
Testosterone measurement alone in adult males is misleading because it reflects testicular function rather than adrenal androgen control 7.
Failure to screen for TART can result in irreversible gonadal damage; counseling on cryopreservation of semen should be offered when TART is present 5.
Late diagnosis or poor compliance during childhood significantly increases the risk of both central precocious puberty and subsequent adult hypogonadism 2, 8.